Luis P. De Almeida

Coimbra, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Cognitive impairment in SCA3: A multi-center cohort study with demographic, imaging, and biomarker correlates.

Cognitive impairment in SCA3: A multi-center cohort study with demographic, imaging, and biomarker correlates.

Journal: Neurobiology of disease
Published: November 05, 2025

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Journal: Journal of neurodevelopmental disorders
Published: September 16, 2025

Extracellular vesicles-mediated delivery of SpCas9 RNPs for therapeutic gene editing in Spinocerebellar Ataxia Type 3.

Extracellular vesicles-mediated delivery of SpCas9 RNPs for therapeutic gene editing in Spinocerebellar Ataxia Type 3.

Journal: Biomaterials
Published: August 01, 2025

Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis.

Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis.

Journal: Acta neuropathologica communications
Published: June 24, 2025

Optimizing mucosal vaccination: Exploiting Lactobionic acid-modified chitosan for superior gene delivery systems.

Optimizing mucosal vaccination: Exploiting Lactobionic acid-modified chitosan for superior gene delivery systems.

Journal: International journal of biological macromolecules
Published: April 15, 2025

The Therapeutic Potential of Melatonin and Its Novel Synthetic Analogs in Circadian Rhythm Sleep Disorders, Inflammation-Associated Pathologies, and Neurodegenerative Diseases.

The Therapeutic Potential of Melatonin and Its Novel Synthetic Analogs in Circadian Rhythm Sleep Disorders, Inflammation-Associated Pathologies, and Neurodegenerative Diseases.

Journal: Medicinal research reviews
Published: February 27, 2025

Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohort.

Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohort.

Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025

Exploring TLR agonists as adjuvants for COVID-19 oral vaccines.

Exploring TLR agonists as adjuvants for COVID-19 oral vaccines.

Journal: Vaccine
Published: January 15, 2025

Fourier Transform Infrared Spectroscopy Analysis as a Tool to Address Aβ Impact on Extracellular Vesicles.

Fourier Transform Infrared Spectroscopy Analysis as a Tool to Address Aβ Impact on Extracellular Vesicles.

Journal: Molecules (Basel, Switzerland)
Published: November 04, 2024

Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3.

Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3.

Journal: Journal of neurology
Published: September 05, 2024

Restoring neuropetide Y levels in the hypothalamus ameliorates premature aging phenotype in mice.

Restoring neuropetide Y levels in the hypothalamus ameliorates premature aging phenotype in mice.

Journal: GeroScience
Published: August 22, 2024

Isolation of Adeno-associated Viral Vectors Through a Single-step and Semi-automated Heparin Affinity Chromatography Protocol.

Isolation of Adeno-associated Viral Vectors Through a Single-step and Semi-automated Heparin Affinity Chromatography Protocol.

Journal: Journal of visualized experiments : JoVE
Published: April 22, 2024
Showing 1-12 of 47

Last Updated: 09/26/2026